Lymphoma, Leukemia & Myeloma Congress

Thank you to everyone who joined us for this year’s LL&M Congress! Your participation made it a truly impactful event. We hope you gained valuable insights and connections in the fight against hematologic malignancies. We’re excited to announce that we’ll be back next year for our 25th anniversary! Mark your calendars and stay tuned for updates: https://okt.to/suxFkg #LLMCongress #LLMCongress2025

How are you staying up-to-date on the latest hematologic malignancy therapies and research? Join us in Miami from February 7-9 to learn about the latest breakthroughs and insights from leading hematology/oncology conferences worldwide. Register today: https://okt.to/QrLxvE #LLMWinter #LLMWinter2025 #Oncology #Education

That’s a wrap on Lymphoma, Leukemia & Myeloma Congress 2024! Be sure to check out the Oncology Learning Network and the Lymphoma, Leukemia & Myeloma Network to learn more about the exciting developments and thought-provoking discussions happening in the #hematology treatment landscape. #oncology #cancer

That’s a wrap! This week has been full of incredible insights, lively discussions, and shared dedication to advancing care in hematologic malignancies. Thank you to all the attendees, speakers, and experts who made this event unforgettable. Let’s continue pushing the boundaries of cancer research and patient care - See you next year! 👏 #LLMCongress #Hematology #Oncology #MedicalEducation #LLMCongress2024

Join us for our lunch Innovation Theater in Lennox Ballroom at 12:20pm. Long-Term Clinical Data from Multiple Phase 3 Trials for Calquence in the Treatment of CLL/SLL Speakers: Dr. Mihir Raval, MD, MPH Sponsored by: AstraZeneca #LLMCongress #LLMCongress2024

Join us for our lunch Innovation Theater in Empire East at 12:20pm. Optimizing the Patient Journey in CLL: The Path of Least Resistance Speakers: Dr. Matthew Davids, MD, MMSc and Dr. Catherine Coombs, MD Sponsored by: AbbVie #LLMCongress #LLMCongress2024

The last day of LL&M Congress is here! Be sure to check out some of our upcoming general sessions today: 🔺 What To Do with BTK Mutation Data 🔺 Management of Richter Transformation 🔺 Noncovalent Binding BTK inhibitor - A New Novel Approach/A Different Binding Mechanism 🔺 Debate- CLL: Debating Therapeutic Strategies

The last day of LL&M Congress starts now! Let’s close out this incredible event with impactful insights and meaningful connections. Join us for a powerful finish, and be sure to tag us in your social posts. #LLMCongress #LLMCongress2024 #Oncology #Education #NewYork

Thank you to everyone who attended our lunch Innovation Theater this afternoon, and thank you to our sponsor, Bristol Myers Squibb. Tomorrow’s our last day and it’s packed with more educational sessions and opportunities to connect with faculty and colleagues. We look forward to seeing you!

Thanks to all who joined us at our lunch Innovation Theater this afternoon, and thank you to our sponsor, Karyopharmn. We look forward to seeing you at the last session today!